Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adherence to a One-Pill, Once-Daily Antiretroviral Regimen
2007-007839-33Phase 3Completed
- Sponsor
- Papa Giovanni XXIII Hospital
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of efavirenz, emtricitabine and tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV) and retroviral infection, sponsored by Papa Giovanni XXIII Hospital. Primary endpoint: Change in adherence rate with reduced pill burden. Started Jul 2008; status: completed.
02
Drugs
efavirenzemtricitabinetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)retroviral infection
Beyond the preview
Go deeper on 2007-007839-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007839-33.